To assess the risk of disease reactivation during pregnancy after natalizumab suspension in women with multiple sclerosis (MS).
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks
Patti, F
2018-01-01
Abstract
To assess the risk of disease reactivation during pregnancy after natalizumab suspension in women with multiple sclerosis (MS).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Neurology 2018.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Dimensione
891.06 kB
Formato
Adobe PDF
|
891.06 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
